Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 20/20 | 0.45 |
| ▸ | RXRG | P48443 | 16/20 | 0.45 |
| ▸ | RXRB | P28702 | 13/20 | 0.45 |
| ▸ | RARB | P10826 | 9/20 | 0.45 |
| ▸ | RARG | P13631 | 8/20 | 0.45 |
| ▸ | RARA | P10276 | 6/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7732340 | 1.00 | RXRA (0.45) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL7735871 | 0.85 | RXRA (0.52) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL7735872 | 0.85 | RXRA (0.52) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL6915147 | 0.82 | RXRA (0.39) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8005479 | 0.80 | RXRA (0.46) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL7736028 | 0.77 | RXRA (0.53) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL6915152 | 0.77 | RXRA (0.36) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8011708 | 0.76 | RXRA (0.46) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8588550 | 0.75 | RXRA (0.77) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL8588549 | 0.75 | RXRA (0.77) | RXRARXRGRXRBRARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6403638-B1 | COMPOUND FOR USE IN TREATING SKIN DISEASES AND DISORDERS, AND FOR TREATING HYPERVITAMINOSIS A SYNDROME | ALLERGAN SALES, INC. | 2002-06-11 | — | — | US | disclosed |